Systemische und regionale Effekte vasoaktiver Substanzen[1]

Literatur

• 1 Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.  Lancet. 2000;  356 2139-2143
• 2 Bersten A D, Hersch M, Cheung H, Rutledge F S, Sibbald W J. The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis.  Surgery. 1992;  112 549-561
• 3 Bollaert P E, Bauer P, Audibert G, Lambert H, Larcan A. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock.  Chest. 1990;  98 949-953
• 4 Burchardi H, Briegel J, Eckart J. et al . Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin.  Anästhesiologie & Intensivmedizin. 2000;  41 562-631
• 5 De Backer D, Creteur J, Silva E, Vincent J L. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?.  Crit Care Med. 2003;  31 1659-1667
• 6 Dellinger R P, Carlet J M, Masur H. et al . Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.  Intensive Care Med. 2004;  30 536-555
• 7 Desjars P, Pinaud M, Bugnon D, Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock.  Crit Care Med. 1989;  17 426-429
• 8 Desjars P, Pinaud M, Potel G, Tasseau F, Touze M D. A reappraisal of norepinephrine therapy in human septic shock.  Crit Care Med. 1987;  15 134-137
• 9 Di Giantomasso D, Morimatsu H, May C N, Bellomo R. Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine.  Crit Care Med. 2003;  31 2509-2513
• 10 Dive A, Foret F, Jamart J, Bulpa P, Installe E. Effect of dopamine on gastrointestinal motility during critical illness.  Intensive Care Med. 2000;  26 901-907
• 11 Duke G J, Briedis J H, Weaver R A. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine?.  Crit Care Med. 1994;  22 1919-1925
• 12 Dunser M W, Mayr A J, Ulmer H. et al . The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.  Anesth Analg. 2001;  93 7-13
• 13 Giraud G D, MacCannell K L. Decreased nutrient blood flow during dopamine- and epinephrine- induced intestinal vasodilation.  J Pharmacol Exp Ther. 1984;  230 214-220
• 14 Gutierrez G, Clark C, Brown S D. et al . Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients.  Amer J Respir Crit Care Med. 1994;  150 324-329
• 15 Hesselvik J F, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport.  Crit Care Med. 1989;  17 179-180
• 16 Hollenberg S M, Ahrens T S, Astiz M E. et al . Practice parameters for hemodynamic support of sepsis in adult patients in sepsis.  Crit Care Med. 1999;  27 639-660
• 17 Holmes C L, Walley K R, Chittock D R, Lehman T, Russell J A. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series.  Intensive Care Med. 2001;  27 1416-1421
• 18 Kern H, Schroder T, Kaulfuss M. et al . Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients.  Crit Care Med. 2001;  29 1519-1525
• 19 Kiefer P, Tugtekin I, Wiedeck H. et al . Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock.  Am J Respir Crit Care Med. 2000;  161 775-779
• 20 Klinzing S, Simon M, Reinhart K, Bredle D L, Meier-Hellmann A. High-dose vasopressin is not superior to norepinephrine in septic shock.  Crit Care Med. 2003;  31 2646-2650
• 21 Landry D W, Levin H R, Gallant E M. et al . Vasopressin deficiency contributes to the vasodilation of septic shock.  Circulation. 1997;  95 1122-1125
• 22 Leier C V. Regional blood flow responses to vasodilators and inotropes in congestive heart failure.  Am J Cardiol. 1988;  62 86E-93E
• 23 Levy B, Bollaert P E, Charpentier C. et al . Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study.  Intensive Care Med. 1997;  23 282-287
• 24 Levy B, Bollaert P E, Lucchelli J P. et al . Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock.  Crit Care Med. 1997;  25 1649-1654
• 25 MacGregor D A, Prielipp R C, Butterworth J F, James R L, Royster R L. Relative efficacy and potency of beta-adrenoceptor agonists for generating cAMP in human lymphocytes.  Chest. 1996;  109 194-200
• 26 Martikainen T J, Tenhunen J J, Uusaro A, Ruokonen E. The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock.  Anesth Analg. 2003;  97 1756-1763
• 27 Martin C, Eon B, Saux P, Aknin P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients.  Crit Care Med. 1990;  18 282-285
• 28 Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock.  Crit Care Med. 2000;  28 2758-2765
• 29 Meier-Hellmann A, Bredle D L, Specht M, Hannemann L, Reinhart K. Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine.  Crit Care Med. 1999;  27 2166-2171
• 30 Meier-Hellmann A, Bredle D L, Specht M. et al . The effects of low dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock.  Intensive Care Med. 1997;  23 31-37
• 31 Meier-Hellmann A, Reinhart K, Bredle D L. et al . Epinephrine impairs splanchnic perfusion in septic shock.  Crit Care Med. 1997;  25 399-404
• 32 Neviere R, Mathieu D, Chagnon J L, Lebleu N, Wattel F. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients.  Am J Respir Crit Care Med. 1996;  154 1684-1688
• 33 O’Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock.  Lancet. 2002;  359 1209-1210
• 34 Patel B M, Chittock D R, Russell J A, Walley K R. Beneficial effects of short-term vasopressin infusion during severe septic shock.  Anesthesiology. 2002;  96 576-582
• 35 Prielipp R C, MacGregor D A, Royster R L. et al . Dobutamine antagonizes epinephrine’s biochemical and cardiotonic effects: results of an in vitro model using human lymphocytes and a clinical study in patients recovering from cardiac surgery.  Anesthesiology. 1998;  89 49-57
• 36 Reinelt H, Radermacher P, Fischer G. et al . Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock.  Anesthesiology. 1997;  86 818-824
• 37 Silverman H J, Tuma P. Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions.  Chest. 1992;  102 184-188
• 38 Sprung C L, Bernard G R, Dellinger R P. Guidelines for the management of severe sepsis and septic shock.  Intensive Care Med. 2001;  27 1-134
• 39 Tsuneyoshi I, Yamada H, Kakihana Y. et al . Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.  Crit Care Med. 2001;  29 487-493
• 40 Uusaro A, Ruokonen E, Takala J. Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery.  Br J Anaesth. 1995;  74 149-154
• 41 Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment.  Crit Care Med. 1996;  24 1580-1590
• 42 van Haren F M, Rozendaal F W, van der Hoeven J G. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock.  Chest. 2003;  124 2256-2260
• 43 Varga C, Pavo I, Lamarque D. et al . Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat.  Eur J Pharmacol. 1998;  352 257-261
• 44 Vincent J L, Van der Linden P, Domb M. et al . Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration.  Anesth Analg. 1987;  66 565-571

1 Die Arbeit wurde unterstützt durch das Kompetenznetz Sepsis (SepNet), gefördert vom deutschen Bundesministerium für Bildung und Forschung (Förderkennzeichen: 01 KI 0106)